Gian Paolo Ussia

Summary

Publications

  1. doi request reprint Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    EuroIntervention 7:573-9. 2011
  2. doi request reprint Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Catheter Cardiovasc Interv 74:217-22. 2009
  3. doi request reprint Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the Core Valve revalving system-technical tips and role of the Accutrak system
    Kunal Sarkar
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 78:485-90. 2011
  4. doi request reprint Quality of life following percutaneous mitral valve repair with the MitraClip System
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Int J Cardiol 155:194-200. 2012
  5. doi request reprint Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    EuroIntervention 7:1285-92. 2012
  6. doi request reprint Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry
    Gian Paolo Ussia
    Ferrarotto Hospital, Catania, Italy
    Int J Cardiol 167:943-50. 2013
  7. pmc Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study
    Alessio La Manna
    Division of Cardiology, Ferrarotto Hospital, Catania, Italy
    J Cardiovasc Magn Reson 13:82. 2011
  8. doi request reprint [Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?]
    Gian Paolo Ussia
    Ospedale Ferrarotto, Universita di Catania, Catania
    G Ital Cardiol (Rome) 13:356-65. 2012
  9. doi request reprint Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Am J Cardiol 108:1772-6. 2011
  10. doi request reprint Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis
    Gian Paolo Ussia
    Interventional Structural and Congenital Heart Disease Programme, Invasive Cardiology Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Eur Heart J 33:969-76. 2012

Collaborators

Detail Information

Publications49

  1. doi request reprint Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    EuroIntervention 7:573-9. 2011
    ..Quality-of-life (QoL) is a critical measure of effectiveness of TAVI in this patient population. In this prospective study, we sought to assess one year changes in QoL in patients who underwent TAVI...
  2. doi request reprint Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Catheter Cardiovasc Interv 74:217-22. 2009
    ..The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure...
  3. doi request reprint Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the Core Valve revalving system-technical tips and role of the Accutrak system
    Kunal Sarkar
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 78:485-90. 2011
    ..Salient technical expedients have been mentioned and discussed in detail...
  4. doi request reprint Quality of life following percutaneous mitral valve repair with the MitraClip System
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Int J Cardiol 155:194-200. 2012
    ..QoL is a critical measure of effectiveness of this procedure. We sought to evaluate quality of life (QoL) and NYHA class following this novel procedure...
  5. doi request reprint Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    EuroIntervention 7:1285-92. 2012
    ..We investigated the causes of dislocation during TAVI of the self-expanding CoreValve ReValving™ System (CRS) (Medtronic Inc., Minneapolis, MN, USA). This included midterm follow-up of patients experiencing this acute complication...
  6. doi request reprint Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry
    Gian Paolo Ussia
    Ferrarotto Hospital, Catania, Italy
    Int J Cardiol 167:943-50. 2013
    ..We sought to evaluate the impact of CAD on clinical outcomes in patients undergoing TAVI...
  7. pmc Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study
    Alessio La Manna
    Division of Cardiology, Ferrarotto Hospital, Catania, Italy
    J Cardiovasc Magn Reson 13:82. 2011
    ....
  8. doi request reprint [Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?]
    Gian Paolo Ussia
    Ospedale Ferrarotto, Universita di Catania, Catania
    G Ital Cardiol (Rome) 13:356-65. 2012
    ..This approach that reproduces the edge-to-edge technique described by Alfieri, is safe and effective in improving functional class and reducing rehospitalization rates for heart failure patients...
  9. doi request reprint Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Am J Cardiol 108:1772-6. 2011
    ..71) and 6 months (18% vs 15%; p = 0.85). In conclusion, the strategy of adding clopidogrel to aspirin for 3 months after TAVI was not found to be superior to aspirin alone. These results must be confirmed in a larger randomized trial...
  10. doi request reprint Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis
    Gian Paolo Ussia
    Interventional Structural and Congenital Heart Disease Programme, Invasive Cardiology Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Eur Heart J 33:969-76. 2012
    ..We sought to assess 3-year clinical and echocardiographic outcomes of patients undergoing TAVI with the third generation CoreValve prosthesis (Medtronic Incorporation, MN, USA)...
  11. ncbi request reprint Update on percutaneous mitral valve therapy: clinical results and real life experience
    G P Ussia
    Division of Cardiology, University of Catania, Catania, Italy
    Minerva Cardioangiol 60:57-70. 2012
    ..Despite the promising results clinical experience is still small, and no data related the durability are currently available. Therefore, MitraClip device should be reserved now to high risk or inoperable patients...
  12. doi request reprint Management of implant failure during transcatheter aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Catheter Cardiovasc Interv 76:440-9. 2010
    ..There is a paucity of detailed data on the management and outcome of complications related to the sub-optimal deployment of the prosthesis. We appraised the incidence and management of early implant failure occurring during TAVI...
  13. ncbi request reprint Consequences of underexpansion of a percutaneous aortic valve bioprosthesis
    Gian Paolo Ussia
    Invasive Cardiology, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Invasive Cardiol 22:E86-9. 2010
    ..We describe a case of CoreValve self-expanding prosthesis underexpansion, reporting data on prosthesis performance and short-term clinical outcome...
  14. doi request reprint Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip system using conscious sedation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Catheter Cardiovasc Interv 75:1137-40. 2010
    ..Conscious sedation may represent a convenient alternative approach for selected patients who undergo this innovative procedure...
  15. doi request reprint Quality of life assessment after percutaneous aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Via Citelli 6, Catania, Italy
    Eur Heart J 30:1790-6. 2009
    ..To assess the NYHA class and the quality of life (QoL) scores after percutaneous aortic valve implantation (PAVI) with the 18-Fr CoreValve prosthesis...
  16. doi request reprint Aortic valve perforation during aortic valvuloplasty: Identification and strategies for prevention
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy Excellence Through Newest Advances ETNA Foundation, Catania, Italy
    Catheter Cardiovasc Interv 77:876-80. 2011
    ..Failure to recognize cusp perforation can lead to serious procedural complications like severe aortic regurgitation, suboptimal prosthesis deployment, and function that can necessitate emergent open cardiac surgery...
  17. doi request reprint Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 74:607-14. 2009
    ..We report our experience about PFO closure with a bioabsorbable device, BioSTAR (NMT Inc, USA)...
  18. ncbi request reprint Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valve
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Invasive Cardiol 21:E51-4. 2009
    ..Here we describe the case of an 85-year-old female with severe regurgitation of a stentless biological prosthesis treated using the third-generation of CoreValve Revalving System...
  19. doi request reprint The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian CoreValve registry
    Gian Paolo Ussia
    Ferrarotto Hospital, University of Catania, Catania, Italy
    J Am Coll Cardiol 57:1062-8. 2011
    ..We appraised the incidence and clinical outcomes of patients who were treated with the valve-in-valve (ViV) technique for hemodynamically destabilizing paraprosthetic leak (PPL)...
  20. doi request reprint The valve-in-valve technique: transcatheter treatment of aortic bioprothesis malposition
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 73:713-6. 2009
    ....
  21. doi request reprint Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis
    Gian Paolo Ussia
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 76:757-66. 2010
    ..We report our experience about postoperative management protocol adopted in our Division...
  22. doi request reprint Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata
    Corrado Tamburino
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 79:132-40. 2012
    ..To date, there is lack of clarity on data about outcomes of TAVI in lower risk patients. We sought to evaluate the outcomes of patients undergoing TAVI with LES ≥ 20% in comparison with patients with LES < 20%...
  23. doi request reprint Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis
    Valeria Calvi
    Cardiology Department, Ferrarotto Hospital, University of Catania, via Citelli 1, Catania, 95100, Sicily, Italy
    J Interv Card Electrophysiol 34:189-95. 2012
    ..The aim of this study was to assess the incidence rate of conduction disorders and the predictors of postoperative PPM requirement in a large series of patients undergoing TAVI...
  24. doi request reprint Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis
    Corrado Tamburino
    Cardiology Department, Ferrarotto Hospital, University of Catania, Catania, Italy
    Circulation 123:299-308. 2011
    ....
  25. ncbi request reprint Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation
    Gian Paolo Ussia
    Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Invasive Cardiol 22:161-6. 2010
    ..Background. There are no data on BAV use as a bridge to TAVI in patients at high risk of periprocedural complications...
  26. doi request reprint Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves
    Kunal Sarkar
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 81:864-70. 2013
    ..Background: TAVI has emerged as a viable treatment modality for severe aortic stenosis in inoperable or high-risk patients. The use of TAVI for treatment of severe AR has remained largely unexplored...
  27. doi request reprint Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation
    Gian Paolo Ussia
    Division of Cardiology Ferrarotto Hospital, Catania, Italy
    Am Heart J 163:684-9. 2012
    ..We sought to appraise the accuracy of intracardiac echocardiography (ICE) in measurements of structures in the aortic root in patients undergoing TAVI...
  28. doi request reprint Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis
    Corrado Tamburino
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Am J Cardiol 109:1487-93. 2012
    ..In conclusion, in a large observational registry with admitted potential for selection bias and residual confounding, TAVI was not associated with a higher risk of 1-year MACCEs compared to SAVR...
  29. pmc Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting
    Corrado Tamburino
    Cardiology Department, Ferrarotto Hospital, University of Catania, Via Citelli 6, 95124 Catania, Italy
    Eur Heart J 31:1382-9. 2010
    ..8% of patients (95% CI 81.5-99.8). Compared with baseline, left ventricular diameters, diastolic left ventricular volume, diastolic annular septal-lateral dimension, and mitral valve area significantly diminished at 30 days...
  30. doi request reprint Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip system
    Salvatore Scandura
    Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Am Soc Echocardiogr 25:1099-105. 2012
    ..However, specific data on left cardiac chambers reverse remodeling after such procedures are limited...
  31. doi request reprint Percutaneous mitral valve repair in patients with prior cardiac surgery
    Salvatore Scandura
    Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Card Surg 27:295-8. 2012
    ..The aim of this study was to evaluate the outcomes of patients with prior cardiac surgery undergoing MitraClip therapy (Abbott, Abbott Park, Chicago, IL, USA) for severe mitral regurgitation...
  32. ncbi request reprint Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results
    Francesca Mirabella
    Department of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    J Invasive Cardiol 21:145-50. 2009
    ..We sought to evaluate clinical and angiographic outcomes of percutaneous coronary intervention (PCI) in patients receiving both bare-metal stents (BMS) and drug-eluting stents (DES)...
  33. ncbi request reprint Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experience
    Gian Paolo Ussia
    Cardiology Division, University of Catania, Ferrarotto Hospital, Italy
    J Cardiovasc Med (Hagerstown) 7:569-72. 2006
    ..The aim of this study was to assess the safety, feasibility and mid-term efficacy of this procedure...
  34. doi request reprint 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study
    Fabrizio D'Ascenzo
    Division of Cardiology, San Giovanni Battista Molinette, University of Turin, Turin, Italy
    Int J Cardiol 167:1514-8. 2013
    ..In patients undergoing TAVI no study was performed to evaluate outcomes according to renal clearance, which represents the most accurate instrument to assess kidney function...
  35. doi request reprint Gender differences in patients undergoing TAVI: a multicentre study
    Fabrizio D'Ascenzo
    Division of Cardiology, San Giovanni Battista Molinette, University of Turin, Turin, Italy
    EuroIntervention 9:367-72. 2013
    ....
  36. doi request reprint Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases description
    Marco Barbanti
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 78:650-5. 2011
    ....
  37. doi request reprint Trans catheter aortic valve implantation with core valve revalving system in uncoiled (horizontal) aorta. Overcoming anatomical and technical challenges for successful deployment
    Kunal Sarkar
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Catheter Cardiovasc Interv 78:964-9. 2011
    ..Familiarity and facility with retrieval techniques using a snare catheter is desirable in cases of implant failure...
  38. doi request reprint Transcatheter aortic valve implantation: what has been done and what is going to be done
    Corrado Tamburino
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy and ETNA Foundation, Catania, Italy
    Future Cardiol 6:83-95. 2010
    ..This paper aims to go over all the current devices, from the most widely used to the newest technology, focusing on device description, procedural issues, potential complications and clinical studies currently available in literature...
  39. ncbi request reprint Images in cardiovascular medicine. Late device dislodgement after percutaneous closure of mitral prosthesis paravalvular leak with Amplatzer muscular ventricular septal defect occluder
    Gian Paolo Ussia
    Cardiovascular Department, Ferrarotto Hospital, Catania, Italy
    Circulation 115:e208-10. 2007
  40. doi request reprint Transesophageal echocardiography and transcranial color Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale?
    Sarah Mangiafico
    Department of Internal Medicine and Systemic Disease, Clinical Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    J Cardiovasc Med (Hagerstown) 10:143-8. 2009
    ..The purpose of this study was to compare the practical use of contrast-enhanced transcranial color Doppler (c-TCD) to define its role in the diagnostic pathway of patent foramen ovale...
  41. doi request reprint [Management of severe stenosis controversies and promises]
    Marco Barbanti
    Dipartimento di Cardiologia, Ospedale Ferrarotto, Universita di Catania
    Recenti Prog Med 102:374-9. 2011
    ..This review aims to go over some of the most hot issues currently debated on this topic...
  42. ncbi request reprint Chronic embolization of an atrial septal occluder device: percutaneous or surgical retrieval? A case report
    Gian Paolo Ussia
    Division of Paediatric Cardiology, Ferrarotto Hospital, Catania, Italy
    J Cardiovasc Med (Hagerstown) 8:197-200. 2007
    ..We describe a case of late device embolization occurring two years after transcatheter atrial septal defect closure and for which percutaneous retrieval was unsuccessfully attempted...
  43. doi request reprint Early conduction disorders following percutaneous aortic valve replacement
    Valeria Calvi
    Cardiology Department, Ferrarotto Hospital, University of Catania, Catania, Italy
    Pacing Clin Electrophysiol 32:S126-30. 2009
    ..We examined the incidence and characteristics of CD in the immediate postoperative period after PAVR, and the need for permanent pacemaker (PPM) implantation...
  44. pmc Early restenosis after drug-eluting stent implantation: A putative role for platelet activation
    Corrado Tamburino
    Institute of Cardiology, Ferrarotto Hospital, University of Catania, Italy
    Can J Cardiol 23:57-9. 2007
    ..Extremely careful follow-up is mandatory after the recognition of intraluminal thrombi inside DES because restenosis may occur at the same site of DES thrombosis...
  45. ncbi request reprint Intracardiac echocardiography using the AcuNav ultrasound catheter during percutaneous closure of multiple atrial septal defects
    Gian Paolo Ussia
    Pediatric Cardiology, Ferrarotto Hospital, Catania, Italy
    Ital Heart J 5:392-5. 2004
    ..We describe the usefulness of a new phased-array ultrasound-tipped catheter for intracardiac echocardiography in a case of percutaneous closure of multiple ostium secundum atrial septal defects...
  46. doi request reprint Percutaneous aortic valve replacement in a 65-year old patient with thalassemia intermedia: A case report
    Rosamaria Rosso
    Department of Thalassemia, S Bambino Hospital, Catania, Italy
    Transfus Apher Sci 43:189-92. 2010
    ..PARV was a safe and a valid therapeutic approach dramatically to improve the clinical evolution of cardiomyopathies in our patient...
  47. doi request reprint Late MitraClip procedure after left atrial appendage occlusion: indication and procedure description
    Valeria Cammalleri
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Catheter Cardiovasc Interv 83:291-6. 2014
    ....
  48. doi request reprint Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents
    Alfredo R Galassi
    Department of Internal Medicine and Systemic Disease, Clinical Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    JACC Cardiovasc Interv 2:185-94. 2009
    ..This retrospective study sought to assess the clinical and angiographic long-term outcome after implanting drug-eluting stents in bifurcation lesions with the T-provisional (T-prov) technique and mini-crush (MC) technique...
  49. ncbi request reprint Reduction of mitral valve regurgitation with Mitraclip® percutaneous system
    C Tamburino
    Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    Minerva Cardioangiol 58:589-98. 2010
    ..Although the field of percutaneous management of MR is at an early stage, it has been demonstrated that percutaneous approaches can reduce MR, suggesting there is a great deal of potential for clinical benefit to patients with MR...